← All stocks

Sana Biotechnology, Inc.

SANA Net buying
CIK 0001770121 #2466 in the set updated 22 Sep 2026
Bought (120 mo)
$30.70M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.28M
$1.50M on a plan · $1.99M straight out of an exercise
Sold at will
$9.79M
19 of 31 sales
Net
+$17.43M
+$20.92M against sales at will

By person

19 insiders · 43 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ARCH Venture Fund X, L.P. entity
10% owner
$10.00M (3)
+$10.00M
24,164,772
8.07%
$175.44M
CRANDELL KEITH
10% owner
$10.00M (3)
+$10.00M
12,446,022
4.16%
$90.36M
+17.1%
NELSEN ROBERT
Director
$10.00M (3)
+$10.00M
24,178,625
8.08%
$175.54M
Flagship Ventures Fund V General Partner LLC entity
10% owner
$6.06M (10)
−$6.06M
12,965,476
4.33%
$94.13M
Hordo Christian
EVP, Chief Business Officer
$2.33M (11) scheduled
−$2.33M
867,455
0.2898%
$6.30M
−11.0%
FMR LLC entity
10% owner
$1.89M (4)
−$1.89M
4,541,511
1.52%
$32.97M
−6.0%
AGARWAL SUNIL
EVP, Head of Development & CMO
$1.56M (2)
−$1.56M
1,550,000
0.5178%
$11.25M
−3.7%
Mulligan Richard
Director
$1.20M (2) scheduled
−$1.20M
2,698,121
0.9013%
$19.59M
−10.0%
Bilenker Joshua H.
Director
$500.00K (1)
+$500.00K
20,000
0.0067%
$145.20K
Yang Patrick Y
Director
$204.40K (1)
$236.30K (1)
−$31.90K
149,250
0.0499%
$1.08M
+2.1%
MacDonald James J.
EVP & General Counsel
$2.09K (1)
−$2.09K
755,208
0.2523%
$5.48M
+29.1%
Harr Steve
President & CEO
8,626,751
2.88%
$62.63M
+26.4%
Bishop Hans Edgar
Director
5,854,800
1.96%
$42.51M
+58.0%
von Maltzahn Geoffrey
Director
1,830,610
0.6115%
$13.29M
Wyrick Susan D.
See Remarks
196,196
0.0655%
$1.42M
+25.4%
PATEL DHAVALKUMAR DHIRAJLAL
EVP, Chief Scientific Officer
183,352
0.0612%
$1.33M
+84.3%
Cassidy Bernard J
EVP & General Counsel
112,990
0.0377%
$820.31K
+7.8%
Wilderotter Mary Agnes
Director
7,106
0.0024%
$51.59K
Flagship Pioneering, LLC entity
10% owner
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
MacDonald James J.
13 Jun 2022
EVP & General Counsel
Exercised, kept
66,796
$1.48
$98.86K

What was left out

Form 4 filings counted 145
Amendments (4/A) skipped 19
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 9
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 184,287,061
Sales filed before the plan box existed 4
History held since 5 Feb 2021